Skip to main content
Download PDF

Association of personality traits with polypharmacy among community-dwelling older adults in Japan: a cross-sectional analysis of data from the SONIC study

BMC Geriatrics volume 22, Article number: 372 (2022) Cite this article

Abstract

Background

Polypharmacy is a serious concern among older adults and is frequently related to adverse outcomes, including health problems, reduced quality of life, and increased medical expenses. Although personality traits are associated with health behaviors and diseases, the effect of polypharmacy on personality traits is unclear. Therefore, we examined the association of personality traits with polypharmacy among community-dwelling older adults.

Methods

This cross-sectional study analysed data on 836 community-dwelling older adults aged 69–71 years who participated in the Japanese longitudinal cohort study of Septuagenarians, Octogenarians, and Nonagenarians Investigation with Centenarians. Polypharmacy was defined as the intake of ≥ 5 medications concurrently. Personality traits were assessed using the Japanese version of the NEO-Five-Factor Inventory (NEO-FFI). A five-factor model of personality traits, including “neuroticism,” “extraversion,” “openness,” “agreeableness,” and “conscientiousness,” was measured by the NEO-FFI.

Results

The average number of medications was about 3 in both men and women. Among the participants, polypharmacy was observed in 23.9% of men and 28.0% of women. Multivariable logistic regression analysis showed that neuroticism (adjusted odds ratio [aOR] per 1 point increase = 1.078, 95% confidence interval [CI] = 1.015–1.144) in men and extraversion (aOR = 0.932, 95% CI = 0.884–0.983) in women were associated with polypharmacy.

Conclusions

Higher neuroticism in men and lower extraversion in women were associated with polypharmacy. This study suggests that personality traits may be involved in the process leading to the development of polypharmacy. Information on individual personality traits may help medical professionals in decision-making regarding medication management for lifestyle-related diseases.

Peer Review reports

Background

Most “baby boomers” will be aged > 75 years by 2025, and the number of older adults is expected to continually increase worldwide, including in Japan. Hence, it is necessary to create an environment where people can live safely in the community for as long as possible, even if medical and nursing care is required [1]. People aged > 75 years frequently experience increasing health problems and multimorbidity. The increase in multimorbidity with age leads to an increase in polypharmacy in older adults [2]. Polypharmacy is a common condition among older people, with prevalence ranging from 26.3% to 39.9% in European countries [3], Another study found the prevalence to range from 27 to 59%, in a review of 14 studies [4]. Therefore, it is recommended to use Beers Criteria [5], the STOPP/START criteria [6], and CRIME [7] to avoid inappropriate drug use and polypharmacy in each country. Therefore, polypharmacy has become a public health problem worldwide.

Polypharmacy is defined as the simultaneous use of several medications by a single individual. Previous studies have shown that polypharmacy among older adults is associated with adverse health outcomes such as falls [8, 9], reduced mobility [10, 11], cognitive impairment [11, 12], frailty [13, 14], and mortality [15, 16]. This increase in adverse health outcomes and the consequent increase in medical expenses impair the quality of life (QOL) of older adults [3]. Although multidrug therapy is an established and frequently effective treatment method, it should be used with caution in older adults with impaired physiology.

The most influential factors related to polypharmacy are older age [3, 17, 18] and the number of chronic diseases [3]. However, several other factors have also been shown to be associated with polypharmacy. For example, sociodemographic and lifestyle factors have been reported to be associated with polypharmacy. Additionally, several studies have found that low education levels [3, 17, 19], low economic status [3], physical inactivity [3], smoking [17], and drinking [18] are associated with polypharmacy.

Furthermore, psychosocial factors have been reported to be associated with polypharmacy. Previous studies have reported that self-related health [20], quality of life, and network satisfaction [3] are associated with polypharmacy. The relationship between personality traits and polypharmacy in older adults has also been reported. Personality traits are defined as “dimensions of individual differences in tendencies to show consistent patterns of thoughts, feelings, and actions” [21]. The five-factor model of personality traits consists of five major domains—neuroticism, extraversion, openness, agreeableness, and conscientiousness [22]. In addition, a previous study has shown that neuroticism is associated with polypharmacy [23]. Three possible pathways are underlying the association between personality traits and polypharmacy—lifestyle, illness, and thinking styles and attitudes. Personality traits affect an individual’s health behaviors such as smoking, alcohol intake, dietary pattern [24]. In addition, personality traits are associated with chronic diseases, for which many drugs are prescribed, such as diabetes mellitus [25], sleep disorder [26], cognitive impairment [27], and infection [28]. Personality traits are also predictors of all-cause mortality among community-dwelling older adults [29]. In addition, personality traits are associated with treatment perceptions and desires [30]. This suggests that personality traits are associated with health behaviors such as medication management and consultation behaviors, and thus, they may be involved in several processes leading to polypharmacy.

There are a limited number of studies that examined the relationship of personality traits with polypharmacy among older adults. Investigating this relationship may improve the understanding of the mechanisms underlying the high prevalence of polypharmacy among older adults and help develop more effective strategies for preventing improper medication use. In particular, personality traits may provide valuable information to determine which methods are appropriate for treatment and medical and behavioral interventions. Thus, this study aimed to explore the association of personality traits with polypharmacy among community-dwelling older adults.

Methods

Sample and participants

The data reported in this cross-sectional study were obtained from the first wave of the Japanese longitudinal cohort study of Septuagenarians, Octogenarians, and Nonagenarians Investigation with Centenarians (SONIC). The SONIC study used a narrow age-range cohort design. Data were collected for the 70-year-old cohort in 2010. Participants were randomly selected from the resident registry from the following urban and rural areas in Japan: Itami City, Hyogo (Western urban); Asago City, Hyogo (Western rural); Itabashi Ward, Tokyo (Eastern urban); and Nishitama County (Ome City, Okutama Town, Hinode Town, and Hinohara Village), Tokyo (Eastern rural). The participants were all volunteers living independently; no institutionalized individuals were included. A detailed description of the study design and protocol has been published elsewhere [31].

A total of 4307 residents in the 70-year-old cohort who were randomly selected from local residential registries were invited to participate in this study. The invitation letters sent out to invitees described the purposes of the SONIC study and its methodology. We asked them to send back an agreement letter, wherein invitees indicated the appropriate date and time of participation if they were interested. In total, 1000 community-dwelling older adults aged 69–71 years (479 men and 521 women) participated in the study. Of these 1000 participants, 164 participants were excluded from the analysis owing to missing medication status (n = 2), personality traits data (n = 132), subjective economic status (n = 5), smoking habits (n = 2), alcohol consumption (n = 18), and instrumental activities of daily living (IADL) (n = 5). Therefore, the data on 836 participants (397 men and 439 women) were used for this study.

Data for the SONIC study were primarily collected by administering questionnaires to participants. The questionnaires contained items designed to identify sociodemographic status, psychosocial characteristics, medical conditions, dental conditions, and lifestyles.

Data collection

The participants were invited to the health examination survey. A questionnaire was mailed in advance to the participants’ homes and filled out by each participant. At the time of the health examination survey, missing or illogical answers to questions included in the questionnaire were checked in face-to-face interviews conducted by trained interviewers.

Measurements

Polypharmacy

Participants reported their current medication status before their health examination using a questionnaire, and they brought a personal medication record to the health examination. A medication record or medicine information sheet is usually provided to patients when a physician prescribes medications. Based on the data from the questionnaire and medication record, a physician or a health professional interviewed the participants and reconfirmed their drugs, including prescription names, dosages, and duration of medications. In addition, over-the-counter drugs were not included. Polypharmacy was defined as the intake of ≥ 5 medications concurrently [15].

Personality traits

Personality traits were evaluated using the NEO-Five-Factor Inventory (NEO-FFI), a widely replicated model of personality [32]. We used the Japanese version of the NEO-FFI [33]. A five-factor model of personality traits, including “neuroticism,” “extraversion,” “openness,” “agreeableness,” and “conscientiousness,” was measured by the NEO-FFI. In the SONIC study, participants were asked to indicate their level of agreement on a 5-item Likert scale ranging from strongly disagree to strongly agree, with 60 statements regarding the five domains of personality traits. The total scores were calculated by summing the scores for the 12 items representing each domain after reversing negatively keyed items, resulting in variables with scores ranging from 0 to 48.

Other variables

The questionnaire contained items assessing demographic information, including sex, age, subjective economic status, and participants’ health-related behaviors, including smoking habits (currently or not) and alcohol consumption (currently or not).

Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters squared), measured during health examinations. Participants’ chronic disease history was evaluated based on questions regarding a history of hypertension, diabetes mellitus, hyperlipidemia, cancer, coronary heart disease, cerebrovascular disease, tuberculosis, pneumonia, gastric or liver disease, renal or prostate disease, osteoporosis, musculoskeletal disease, trauma, dementia, Parkinson’s disease, eye disease, ear disease, and other diseases. A physician or a health professional confirmed participants’ chronic disease history during the health examination.

IADL were evaluated using five items of instrumental self-maintenance, a subcategory of the 13-item Tokyo Metropolitan Institute of Gerontology Index of Competence [34]. Participants answered “yes” or “no” to the following five questions: “Can you use public transportation (bus or train) by yourself?”; “Are you able to shop for daily necessities?”; “Are you able to prepare meals by yourself?”; “Are you able to pay bills?”; and “Can you handle your own banking?”. Each item was scored 1 for “yes” and 0 for “no.” A score of 5 points indicated “independence,” and a score of ≤ 4 points showed “dependence” [35].

Mental health status was assessed using the Japanese version of the World Health Organization-Five Well-Being Index (WHO-5-J) [36]. The WHO-5-J is a self-administered questionnaire comprising five items. Item scores were summed to obtain a total score (range 0–25), with higher scores reflecting a higher level of subjective well-being. A score of ≥ 13 points indicated “no depression,” and a score of < 13 points indicated “depression.”

Statistical analysis

We used the chi-square test to compare categorical variables and the t-test or analysis of variance to compare continuous variables. Multivariable logistic regression was used to determine the association between personality traits and polypharmacy. The multivariable logistic regression model was adjusted for the subjective economic situation, alcohol consumption and smoking habits, BMI, chronic diseases, IADL, and mental health status. Since there are sex differences between personality traits [37] and polypharmacy [3], separate analyses were performed for men and women. Multicollinearity (variance inflation factor) is less than 1.5 for each variable, for both men and women. The odds ratio per 0.5 SD, which corresponds to the minimal important difference [38] or each personality trait score, was also calculated.

All statistical analyses were performed using IBM SPSS 25.0 for Windows (IBM Corp., Armonk, NY, USA). A two-tailed p-value of < 0.05 was considered statistically significant.

Ethical considerations

The study protocol was approved by the Institutional Review Boards of Osaka University Graduate Schools of Medicine, Dentistry, and Human Sciences and the Ethics Committee of Tokyo Metropolitan Institute of Gerontology. All participants provided written informed consent to participate.

Results

The reliability of each domain of personality traits in this analysis was relatively high, with Cronbach’s alpha coefficients for neuroticism, extraversion, openness, agreeableness, and conscientiousness of 0.74, 0.75, 0.58, 0.70, and 0.73, respectively. The characteristics of the participants are provided in Table 1. Overall, 90.8% of participants were functionally independent. The mean ± standard deviation (SD) of the number of medications was 2.8 ± 2.8 in men and 3.1 ± 3.2 in women. The prevalence of polypharmacy was 23.9% and 28.0% in men and women, respectively. The mean scores (± SD) for neuroticism were 20.7 ± 5.3 in men and 22.3 ± 5.5 in women, those for extraversion were 26.6 ± 5.2 in men and 26.5 ± 5.2 in women, those for openness were 26.3 ± 4.3 in men and 27.2 ± 4.4 in women, those for agreeableness were 30.6 ± 4.2 in men and 32.7 ± 4.4 in women, and those for conscientiousness were 30.0 ± 4.7 in men and 30.0 ± 5.1 in women.

Table 1 Participant characteristics
Full size table

Table 2 shows the characteristics of the participants with and without polypharmacy according to sex. In the comparison of the characteristics of participants with and without polypharmacy, women with polypharmacy were significantly more likely to be in an "economically difficult" situation than women without polypharmacy (p < 0.05). Women with polypharmacy were significantly less likely to have a drinking habit (p < 0.01). Both men and women with polypharmacy were significantly more likely to have three or more chronic conditions (both p < 0.001).

Table 2 Characteristics of participants with and without polypharmacy
Full size table

As presented in Table 3, multivariable logistic regression analysis showed that neuroticism (adjusted odds ratio [aOR] per 1 point increase = 1.078, 95% confidence interval [CI] = 1.015–1.144) was significantly associated with polypharmacy in men, while extraversion (aOR = 0.932, 95% CI = 0.884–0.983) was significantly associated with polypharmacy in women. Additionally, the odds ratio per 0.5 SD, which corresponds to minimal important difference for each personality trait score, was 1.223 (95% CI = 1.041–1.434) for neuroticism in men and 0.831 (95% CI = 0.722–0.956) for extraversion in women.

Table 3 Associations between personality traits and polypharmacy
Full size table

Discussion

The results showed that higher levels of neuroticism and lower levels of extraversion were significantly associated with polypharmacy in men and women, respectively. The odds ratio per 0.5 SD for each personality trait score provided similar results.

This study showed that higher neuroticism was associated with polypharmacy in men. Neuroticism is characterized by emotional anxiety and vulnerability to stress. Neuroticism may influence lifestyle and lead to susceptibility to disease as a result. Previous studies have shown that higher levels of neuroticism are associated with smoking [39] and physical inactivity [40]. Further, consumption of more grains and dairy products, fish, vegetables, and fruits, has been associated with lower levels of neuroticism [41]. Thus, personality traits affect the lifestyles, resulting in unhealthy lifestyles that can lead to increased disability and increased mortality. Furthermore, personality traits may affect particular illnesses that require more medications, such as depression and diabetes mellitus. According to the studies on personality traits and diseases, higher levels of neuroticism are associated with depression [42], diabetes mellitus [25], and mild cognitive impairments [27]. Therefore, people with higher levels of neuroticism may be more prone to polypharmacy. Moreover, personality traits may affect attitude or thinking and behavior during illness. A previous study showed that regardless of the severity of anxiety and depression, patients with higher levels of neuroticism were more likely to have a perceived need for care [30]. ten Have et al. [43] have reported that people with high levels of neuroticism were more likely to receive care in the specialized mental health sector and visit healthcare services. Thus, people with higher levels of neuroticism may be more likely to report many symptoms, and this may prompt their doctors to prescribe many medications.

This study also showed that lower levels of extraversion were associated with polypharmacy in women. Extraversion is characterized by gregariousness, active and positive emotions. There have been studies on the relationship between extraversion and lifestyle. Previous studies have shown that lower levels of extraversion were negatively associated with healthy aware diet [41]. Previous studies have also shown that lower levels of extraversion were associated with physical inactivity [40, 44]. Moreover, extraverted people are likely to have healthier behaviors and better health, which may result in more prolonged survival [45]. Thus, personality traits can affect lifestyles, resulting in unhealthy lifestyles that can lead to increased disability and mortality. Furthermore, it is possible that personality traits with lower levels of extraversion affect a particular illness requiring many medications. Previous studies have shown that lower levels of extraversion are related to depression [42, 46] and infectious disease [28]. In addition, higher levels of extraversion have a protective effect against death from respiratory disease [47]. Although no data were shown in this study, there was a negative correlation between extraversion and lung disease in women, consistent with the findings of previous studies [47]. Moreover, personality traits with lower levels of extraversion may affect attitude or thinking and behavior during illness. As the characteristics of low levels of extraversion include the tendency to be reserved, retiring, and withdrawn [22], individuals with low levels of extraversion may not communicate their health problems to health care professionals. Lack of communication between healthcare professionals and patients can interfere with an accurate diagnosis by healthcare professionals, leading to multidrug prescriptions and multiple medical treatments. Additionally, in previous studies, extraversion was associated with social relationships [48] and positively correlated with affectionate support [49]. Therefore, people with lower levels of extraversion are poorly supported, and this can make their medical conditions more serious, leading to multiple drug use.

The results of this study suggest that personality traits may affect the development of illness and medication usage (polypharmacy). However, the causal pathway by which personality traits are related to polypharmacy is unclear. There are several possible mechanisms by which personality traits may lead to polypharmacy; these include: (1) personality traits may influence lifestyle, and an unhealthy lifestyle makes individuals more prone to disease; (2) personality traits may influence the manifestation and severity of a specific illness, thus influencing the amount of medication that is required; and (3) personality traits may affect thinking and behavior patterns during illness, which may affect the use of medical services, treatment needs, and communication with doctors.

This study identified a sex difference, in that different personality traits were associated with polypharmacy. Furthermore, the background between personality and polypharmacy may have different pathways depending on sex. Because, in addition to body composition, organ, and metabolism, there are sex differences in lifestyles, such as drinking, smoking, physical activity [50], dietary intake [51], and factors leading to long-term care [52]. In addition to the occurrence of sex-specific morbidities due to the above factors, personality-specific medical treatment behaviour may have affected the number of medications taken. Sex differences need to be examined in detail in the future.

In addition to personality traits, not having a drinking habit and having a high number of chronic diseases were independently associated with polypharmacy. Similar to the present study, a previous study reported that having a drinking habit was inversely associated with polypharmacy; that is, an increase in the frequency of alcohol consumption led to a decrease in polypharmacy [18]. Although a causal relationship cannot be claimed, this being a cross-sectional study, it was estimated that people with chronic diseases may be more likely to quit drinking. It has also been reported that a high number of chronic diseases was associated with polypharmacy [3], which is consistent with the present study.

This study has some strengths. First, personality traits were based on a self-reported questionnaire. In this study, the NEO-FFI was used to evaluate personality traits. The NEO-FFI was developed by Costa et al. [32], and the reliability and validity of the Japanese version of the NEO-FFI have been verified by Shimonaka et al. [33]. The NEO-FFI is a stable and standard measure and is often used in gerontological studies. In addition, data on medication status were also collected through interviews. To minimize the inaccuracy of the medication status due to self-reports, we asked participants to bring their medication records. Based on data in this record, the physician confirmed the medication status in face-to-face interviews. Therefore, the number of prescriptions was accurate. Second, a limited number of studies have examined the relationship between personality traits and polypharmacy in older adults. Some studies on personality traits and polypharmacy have focused on patients with impaired mental health. A previous study on older adults with mental illness found that neuroticism was associated with polypharmacy [23]. In addition, low levels of openness, extraversion, and conscientiousness have been reported to be associated with increased psychotropic medication use in patients with bipolar disorder [53]. This study provides new findings regarding the relationship between personality traits and polypharmacy in community-dwelling older adults.

However, this study has some limitations. First, there is a possibility of residual confounding. The results showed that personality traits were associated with polypharmacy. The variables adjusted in the analysis of the relationship between personality traits and polypharmacy included economic status as socio-economic factors; drinking and smoking status as lifestyle-related factors; and BMI, IADL, mental health, and the number of chronic diseases as health status factors. Even after adjusting for various aspects of health status, the association remained significant, so poor health status did not completely explain the number of medications prescribed to older adults. In addition, since mental illness measures were not included in the medical history, the WHO-5-J was used as an adjusting variable in the model. Therefore, the effects of mental illness were considered adjustable. Furthermore, although the data are not presented in this study, neuroticism in men and extroversion in women remain significantly associated with polypharmacy after adjusting for psychiatric drug use. However, although several factors were controlled for in the analyses, residual confounders, such as social support and social network, might be present. It has been reported that social support is associated with better self-care compliance among older patients [54]. In addition, inclusion in social networks is associated with healthy behavior [55] and a reduced risk of depressive symptoms [56]. Therefore, if the analysis is adjusted for social factors, the strength of association between personality traits and polypharmacy may be weakened.

Second, the representativeness may be limited. The participation rate of this study was 23.2%, which is a low rate. The participants had at least a degree of independence as they could attend the study venue independently. Most participants were physically and cognitively healthy; therefore, people with poor health status may not have participated in this study. Conversely, most individuals in their 70 s are independent and active. It is possible that the low participation rate in the survey was because potential participants were engaged in work or leisure activities.

Third, there were cultural differences. The participants in this study were older adults living in Japan. Therefore, attention should be paid when generalizing the study results to other countries with different medical systems and cultural backgrounds. It is necessary to consider whether personality traits are commonly associated with polypharmacy, even in older adults with diverse backgrounds.

Fourth, a causal relationship was not described. Because the study was a cross-sectional study, our findings could not identify causal relationships. However, personality traits influence lifestyle [24, 40, 44] and behavior [30, 43]. A previous study of depressed patients found that the use of medication decreased neuroticism, increased extroversion and reduced depression [57]. However, these results are inconsistent with the results of our study. Approximately 50% of personality traits are attributable to additive genetic effects [58], and personality is stable after 30 years of age [32]. Therefore, the effect of polypharmacy on personality is likely to be small. Longitudinal research is required to clarify causal relationships in the future.

Nevertheless, our results suggest that personality traits may be involved in the process of disease outbreaks or behaviors toward treatment. The relationship between personality traits and various emotional reactions and behaviors is a common phenomenon. Therefore, understanding the personality traits of individuals will be helpful in effective treatment and health interventions in independent community-dwelling older adults. In particular, personality traits may be beneficial in the prevention and management of unhealthy lifestyles, such as unbalanced dietary habits, physical inactivity, smoking, and lifestyle-related diseases caused by unhealthy lifestyles. More specifically, information on the patient’s personality traits may contribute to (1) diagnosis that considers unhealthy lifestyles and illness trends, (2) treatment plan that considers the patient’s request and attitude toward treatment, communication style, and support status, and (3) intervention design suitable for each personality trait, such as group and individual interventions.

The study results showed that higher levels of neuroticism and lower levels of extraversion in men and women, respectively, are associated with polypharmacy. Therefore, to avoid polypharmacy, it is necessary to prevent and improve unhealthy habits and mental health deterioration in men with higher levels of neuroticism or women with lower levels of extraversion. In addition, since patients with higher levels of neuroticism tend to require more medications and treatments, it is necessary to control anxiety and prevent excessive medical care in patients. Furthermore, since lower levels of extraversion involve poor communication or support, it is necessary to understand patients' symptoms by creating an environment that enhances communication and provides care considering the support environment of the patients.

Conclusions

In conclusion, this cross-sectional study showed that personality traits, especially higher levels of neuroticism in men and lower levels of extraversion in women, were associated with polypharmacy, even after adjusting for potential confounding factors. This study suggests that personality traits may affect medication usage in older adults and need to be considered in managing polypharmacy.

Availability of data and materials

The datasets generated and/or analysed during the current study are not publicly available due to privacy/ethical restrictions but are available from the corresponding author on reasonable request.

Abbreviations

aOR:

Adjusted odds ratio

BMI:

Body Mass Index

CI:

Confidence interval

IADL:

Instrumental of activity if daily living

NEO-FFI:

The NEO-Five-Factor Inventory

SD:

Standard deviation

SONIC:

Septuagenarians, Octogenarians, and Nonagenarians Investigation with Centenarians

WHO-5-J:

The World Health Organization-Five Well-Being Index

References

  1. Ministry of Health LaW. Annual Health, Labour and Welfare Report 2017 -Social Security and Economic Growth-. 2017. p. 312.

    Google Scholar 

  2. Ishizaki T, Mitsutake S, Hamada S, Teramoto C, Shimizu S, Akishita M, et al. Drug prescription patterns and factors associated with polypharmacy in >1 million older adults in Tokyo. Geriatr Gerontol Int. 2020;20(4):304–11. https://doi.org/10.1111/ggi.13880.

    Article  PubMed  Google Scholar 

  3. Midao L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–20. https://doi.org/10.1016/j.archger.2018.06.018.

    Article  PubMed  Google Scholar 

  4. Elmståhl S, Linder H. Polypharmacy and inappropriate drug use among older people–A systematic review. Healthy Aging & Clinical Care in the Elderly. 2013;5:1–8. https://doi.org/10.4137/HACCE.S11173.

    Article  Google Scholar 

  5. Society TAG. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.

    Article  Google Scholar 

  6. Carvalho R, Lavrador M, Cabral AC, Veríssimo MT, Figueiredo IV, Fernandez-Llimos F, et al. Patients’ clinical information requirements to apply the STOPP/START criteria. Int J Clin Pharm. 2019;41(6):1562–9. https://doi.org/10.1007/s11096-019-00920-5.

    Article  PubMed  Google Scholar 

  7. Onder G, Landi F, Fusco D, Corsonello A, Tosato M, Battaglia M, et al. Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging. 2014;31(1):33–45. https://doi.org/10.1007/s40266-013-0134-4.

    Article  PubMed  Google Scholar 

  8. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61(2):218–23. https://doi.org/10.1111/j.1365-2125.2005.02543.x.

    CAS  Article  PubMed  Google Scholar 

  9. Montero-Odasso M, Sarquis-Adamson Y, Song HY, Bray NW, Pieruccini-Faria F, Speechley M. Polypharmacy, Gait Performance, and Falls in Community-Dwelling Older Adults. Results from the Gait and Brain Study. J Am Geriatr Soc. 2019;67(6):1182–8. https://doi.org/10.1111/jgs.15774.

    Article  PubMed  Google Scholar 

  10. George C, Verghese J. Polypharmacy and Gait Performance in Community-dwelling Older Adults. J Am Geriatr Soc. 2017;65(9):2082–7. https://doi.org/10.1111/jgs.14957.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Langeard A, Pothier K, Morello R, Lelong-Boulouard V, Lescure P, Bocca ML, et al. Polypharmacy Cut-Off for Gait and Cognitive Impairments. Front Pharmacol. 2016;7:296. https://doi.org/10.3389/fphar.2016.00296.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Niikawa H, Okamura T, Ito K, Ura C, Miyamae F, Sakuma N, et al. Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community. Geriatr Gerontol Int. 2017;17(9):1286–93. https://doi.org/10.1111/ggi.12862.

    Article  PubMed  Google Scholar 

  13. Saum KU, Schottker B, Meid AD, Holleczek B, Haefeli WE, Hauer K, et al. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study. J Am Geriatr Soc. 2017;65(2):e27–32. https://doi.org/10.1111/jgs.14718.

    Article  PubMed  Google Scholar 

  14. Yuki A, Otsuka R, Tange C, Nishita Y, Tomida M, Ando F, et al. Polypharmacy is associated with frailty in Japanese community-dwelling older adults. Geriatr Gerontol Int. 2018;18(10):1497–500. https://doi.org/10.1111/ggi.13507.

    Article  PubMed  Google Scholar 

  15. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95. https://doi.org/10.1016/j.jclinepi.2012.02.018.

    Article  PubMed  Google Scholar 

  16. Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28(7):547–60. https://doi.org/10.2165/11592000-000000000-00000.

    Article  PubMed  Google Scholar 

  17. Castioni J, Marques-Vidal P, Abolhassani N, Vollenweider P, Waeber G. Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study. BMC Health Serv Res. 2017;17(1):840. https://doi.org/10.1186/s12913-017-2793-z.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Slater N, White S, Venables R, Frisher M. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA). BMJ Open. 2018;8(3): e020270. https://doi.org/10.1136/bmjopen-2017-020270.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Carmona-Torres JM, Cobo-Cuenca AI, Recio-Andrade B, Laredo-Aguilera JA, Martins MM, Rodriguez-Borrego MA. Prevalence and factors associated with polypharmacy in the older people: 2006–2014. J Clin Nurs. 2018;27(15–16):2942–52. https://doi.org/10.1111/jocn.14371.

    Article  PubMed  Google Scholar 

  20. Hsu HF, Chen KM, Belcastro F, Chen YF. Polypharmacy and Pattern of Medication Use in Community-dwelling Older Adults: A Systematic Review. J Clin Nurs. 2020. https://doi.org/10.1111/jocn.15595.

    Article  PubMed  Google Scholar 

  21. McCrae RRCP, Jr. Personality in adulthood: A five-factor theory perspective. 2nd ed. New York: Guilford Press; 2003.

    Book  Google Scholar 

  22. McCrae RR, John OP. An introduction to the five-factor model and its applications. J Pers. 1992;60(2):175–215. https://doi.org/10.1111/j.1467-6494.1992.tb00970.x.

    CAS  Article  PubMed  Google Scholar 

  23. Wongpakaran N, Wongpakaran T, Sirirak T, Jenraumjit R, Jiraniramai S, Lerttrakarnnon P. Predictors of polypharmacy among elderly Thais with depressive and anxiety disorders: findings from the DAS study. BMC Geriatr. 2018;18(1):309. https://doi.org/10.1186/s12877-018-1001-2.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bogg T, Roberts BW. Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to mortality. Psychol Bull. 2004;130(6):887–919. https://doi.org/10.1037/0033-2909.130.6.887.

    Article  PubMed  Google Scholar 

  25. Cukić I, Weiss A. Personality and diabetes mellitus incidence in a national sample. J Psychosom Res. 2014;77(3):163–8. https://doi.org/10.1016/j.jpsychores.2014.07.004.

    Article  PubMed  Google Scholar 

  26. Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, et al. Association between insomnia and personality traits among Japanese patients with type 2 diabetes mellitus. J Diab Investig. 2019;10(2):484–90. https://doi.org/10.1111/jdi.12927.

    CAS  Article  Google Scholar 

  27. Luchetti M, Terracciano A, Stephan Y, Sutin AR. Personality and Cognitive Decline in Older Adults: Data From a Longitudinal Sample and Meta-Analysis. J Gerontol B Psychol Sci Soc Sci. 2016;71(4):591–601. https://doi.org/10.1093/geronb/gbu184.

    Article  PubMed  Google Scholar 

  28. Napolioni V, Murray DR, Comings DE, Peters WR, Gade-Andavolu R, MacMurray J. Interaction between infectious diseases and personality traits: ACP1*C as a potential mediator. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2014;26:267–73. https://doi.org/10.1016/j.meegid.2014.06.002.

    CAS  Article  PubMed  Google Scholar 

  29. Iwasa H, Masui Y, Gondo Y, Inagaki H, Kawaai C, Suzuki T. Personality and all-cause mortality among older adults dwelling in a Japanese community: a five-year population-based prospective cohort study. Am J Geriatr Psychiatry. 2008;16(5):399–405. https://doi.org/10.1097/JGP.0b013e3181662ac9.

    Article  PubMed  Google Scholar 

  30. Seekles WM, Cuijpers P, van de Ven P, Penninx BW, Verhaak PF, Beekman AT, et al. Personality and perceived need for mental health care among primary care patients. J Affect Disord. 2012;136(3):666–74. https://doi.org/10.1016/j.jad.2011.10.009.

    CAS  Article  PubMed  Google Scholar 

  31. Gondo Y, Masui Y, Kamide K, Ikebe K, Arai Y, Ishizaki T. SONIC Study: A Longitudinal Cohort Study of the Older People as Part of a Centenarian Study. In: Pachana NA, editor. Encyclopedia of Geropsychology. Singapore: Springer Singapore; 2015. p. 1–10.

    Google Scholar 

  32. Costa PT Jr, McCrae RR. Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Pers Soc Psychol. 1988;54(5):853–63. https://doi.org/10.1037//0022-3514.54.5.853.

    Article  PubMed  Google Scholar 

  33. Shimonaka Y, Nakazato K, Gondo Y, Takayama M. Construction and factorial validity of the Japanese NEO-PI-R. Jpn J Pers. 1998;6(2):138–47. https://doi.org/10.2132/jjpjspp.6.2_138.

    Article  Google Scholar 

  34. Koyano W, Shibata H, Nakazato K, Haga H, Suyama Y. Measurement of competence: reliability and validity of the TMIG Index of Competence. Arch Gerontol Geriatr. 1991;13(2):103–16.

    CAS  Article  Google Scholar 

  35. Fujiwara Y, Shinkai S, Amano H, Watanabe S, Kumagai S, Takabayashi K, et al. Test-retest variation in the Tokyo Metropolitan Institute of Gerontology Index of Competence in community-dwelling older people independent in daily living toward individual assessment of functional capacity. Nihon Koshu Eisei Zasshi. 2003;50(4):360–7.

    PubMed  Google Scholar 

  36. Awata S, Bech P, Koizumi Y, Seki T, Kuriyama S, Hozawa A, et al. Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residents. Int Psychogeriatr. 2007;19(1):77–88. https://doi.org/10.1017/S1041610206004212.

    CAS  Article  PubMed  Google Scholar 

  37. Chapman BP, Duberstein PR, Sörensen S, Lyness JM. Gender Differences in Five Factor Model Personality Traits in an Elderly Cohort: Extension of Robust and Surprising Findings to an Older Generation. Pers Individ Dif. 2007;43(6):1594–603.

    Article  Google Scholar 

  38. Norman GR, Sloan JA, Wyrwich KW. The truly remarkable universality of half a standard deviation: confirmation through another look. Expert Rev Pharmacoecon Outcomes Res. 2004;4(5):581–5. https://doi.org/10.1586/14737167.4.5.581.

    Article  PubMed  Google Scholar 

  39. Hakulinen C, Hintsanen M, Munafo MR, Virtanen M, Kivimaki M, Batty GD, et al. Personality and smoking: individual-participant meta-analysis of nine cohort studies. Addiction. 2015;110(11):1844–52. https://doi.org/10.1111/add.13079.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Allen MS, Walter EE, McDermott MS. Personality and sedentary behavior: A systematic review and meta-analysis. Health Psychol. 2017;36(3):255–63. https://doi.org/10.1037/hea0000429.

    Article  PubMed  Google Scholar 

  41. Mottus R, Realo A, Allik J, Deary IJ, Esko T, Metspalu A. Personality traits and eating habits in a large sample of Estonians. Health Psychol. 2012;31(6):806–14. https://doi.org/10.1037/a0027041.

    Article  PubMed  Google Scholar 

  42. Koorevaar AM, Comijs HC, Dhondt AD, van Marwijk HW, van der Mast RC, Naarding P, et al. Big Five personality and depression diagnosis, severity and age of onset in older adults. J Affect Disord. 2013;151(1):178–85. https://doi.org/10.1016/j.jad.2013.05.075.

    CAS  Article  PubMed  Google Scholar 

  43. ten Have M, Oldehinkel A, Vollebergh W, Ormel J. Does neuroticism explain variations in care service use for mental health problems in the general population? Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 2005;40(6):425–31. https://doi.org/10.1007/s00127-005-0916-z.

    Article  PubMed  Google Scholar 

  44. Ebstrup JF, Aadahl M, Eplov LF, Pisinger C, Jorgensen T. Cross-sectional associations between the five factor personality traits and leisure-time sitting-time: the effect of general self-efficacy. J Phys Act Health. 2013;10(4):572–80. https://doi.org/10.1123/jpah.10.4.572.

    Article  PubMed  Google Scholar 

  45. Rizzuto D, Mossello E, Fratiglioni L, Santoni G, Wang HX. Personality and Survival in Older Age: The Role of Lifestyle Behaviors and Health Status. Am J Geriatr Psychiatry. 2017;25(12):1363–72. https://doi.org/10.1016/j.jagp.2017.06.008.

    Article  PubMed  Google Scholar 

  46. Hakulinen C, Elovainio M, Pulkki-Raback L, Virtanen M, Kivimaki M, Jokela M. Personality and Depressive Symptoms: Individual Participant Meta-Analysis of 10 Cohort Studies. Depress Anxiety. 2015;32(7):461–70. https://doi.org/10.1002/da.22376.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Shipley BA, Weiss A, Der G, Taylor MD, Deary IJ. Neuroticism, extraversion, and mortality in the UK Health and Lifestyle Survey: a 21-year prospective cohort study. Psychosom Med. 2007;69(9):923–31. https://doi.org/10.1097/PSY.0b013e31815abf83.

    Article  PubMed  Google Scholar 

  48. Iveniuk J. Social Networks, Role-Relationships, and Personality in Older Adulthood. J Gerontol B Psychol Sci Soc Sci. 2019;74(5):815–26. https://doi.org/10.1093/geronb/gbx120.

    Article  PubMed  Google Scholar 

  49. Dumitrache CG, Rubio L, Rubio-Herrera R. Extroversion, social support and life satisfaction in old age: a mediation model. Aging Ment Health. 2018;22(8):1063–71. https://doi.org/10.1080/13607863.2017.1330869.

    Article  PubMed  Google Scholar 

  50. Ministry of Health LaW. The National Health and Nutrition Survey in Japan. 2019.

    Google Scholar 

  51. Ledikwe JH, Smiciklas-Wright H, Mitchell DC, Jensen GL, Friedmann JM, Still CD. Nutritional risk assessment and obesity in rural older adults: a sex difference. Am J Clin Nutr. 2003;77(3):551–8. https://doi.org/10.1093/ajcn/77.3.551.

    CAS  Article  PubMed  Google Scholar 

  52. Director-General for Statistics and Information Policy MoH. Graphical Review of Japanese Household. From Comprehensive Survey of Living Conditions, 2019. 2019.

    Google Scholar 

  53. Sachs GS, Peters AT, Sylvia L, Grunze H. Polypharmacy and bipolar disorder: what’s personality got to do with it? Int J Neuropsychopharmacol. 2014;17(7):1053–61. https://doi.org/10.1017/S1461145713000953.

    CAS  Article  PubMed  Google Scholar 

  54. Sayers SL, Riegel B, Pawlowski S, Coyne JC, Samaha FF. Social support and self-care of patients with heart failure. Ann Behav Med. 2008;35(1):70–9. https://doi.org/10.1007/s12160-007-9003-x.

    Article  PubMed  Google Scholar 

  55. Bloom I, Edwards M, Jameson KA, Syddall HE, Dennison E, Gale CR, et al. Influences on diet quality in older age: the importance of social factors. Age Ageing. 2017;46(2):277–83. https://doi.org/10.1093/ageing/afw180.

    Article  PubMed  Google Scholar 

  56. Herbolsheimer F, Ungar N, Peter R. Why Is Social Isolation Among Older Adults Associated with Depressive Symptoms? The Mediating Role of Out-of-Home Physical Activity. Int J Behav Med. 2018;25(6):649–57. https://doi.org/10.1007/s12529-018-9752-x.

    Article  PubMed  Google Scholar 

  57. Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam J, Shelton R, Schalet B. Personality change during depression treatment: a placebo-controlled trial. Arch Gen Psychiatry. 2009;66(12):1322–30. https://doi.org/10.1001/archgenpsychiatry.2009.166.

    Article  PubMed  PubMed Central  Google Scholar 

  58. South SC, Reichborn-Kjennerud T, Eaton NR, Krueger RF. Genetics of personality. Handbook of Psychology, Volume Five: Personality and Social Psychology. Hoboken: Wiley; 2012.

Download references

Acknowledgements

We are grateful to the participants, municipalities, and staff members involved in the SONIC study for their cooperation in this study.

Funding

This work was supported in part by JSPS KAKENHI (Grant Number 21330152 and 19K22790) and a grant from the Tokyo Metropolitan Institute of Gerontology.

Author information

Affiliations

  1. Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, Japan

    Yuko Yoshida, Tatsuro Ishizaki, Yukie Masui & Hiroki Inagaki

  2. Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

    Yasumichi Arai

  3. Osaka University, 2-2 Yamadaoka, Suita, Osaka, Japan

    Madoka Ogawa, Saori Yasumoto, Kei Kamide, Hiromi Rakugi, Kazunori Ikebe & Yasuyuki Gondo

  4. Fukushima Medical University, 1 Hikariga-oka, Fukushima, Japan

    Hajime Iwasa

Authors
  1. Yuko Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tatsuro Ishizaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukie Masui
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasumichi Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroki Inagaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Madoka Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Saori Yasumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hajime Iwasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kei Kamide
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hiromi Rakugi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kazunori Ikebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yasuyuki Gondo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept and design: YY, TI, YM. Acquisition of subjects and/or data: TI, YM, YA, HI, MO, SY, KK, HR, KI, and YG. Analysis and interpretation of data: All authors. Preparation of manuscript: All authors. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Yuko Yoshida.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Tokyo Metropolitan Institute of Gerontology, Osaka University Graduate Schools of Medicine, Dentistry, and Human Science (approval number 38, 266, H22-E9 and 22018, respectively), and with the 1984 Helsinki declaration and its later amendments or comparable ethical standards. All the participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests 

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yoshida, Y., Ishizaki, T., Masui, Y. et al. Association of personality traits with polypharmacy among community-dwelling older adults in Japan: a cross-sectional analysis of data from the SONIC study. BMC Geriatr 22, 372 (2022). https://doi.org/10.1186/s12877-022-03069-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-022-03069-5

Keywords

  • Polypharmacy
  • Neuroticism
  • Extraversion
  • Lifestyle-related disease
  • Psychosocial characteristics

BMC Geriatrics

ISSN: 1471-2318

Contact us